Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.

Alexander C. Ford, Eamonn M M Quigley, Brian E. Lacy, Anthony J. Lembo, Yuri Ann Saito Loftus, Lawrence R. Schiller, Edy E. Soffer, Brennan M R Spiegel, Paul Moayyedi

Research output: Contribution to journalArticle

237 Citations (Scopus)

Abstract

Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder. Evidence relating to the treatment of this condition with antidepressants and psychological therapies continues to accumulate. We performed an updated systematic review and meta-analysis of randomized controlled trials (RCTs). MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were searched (up to December 2013). Trials recruiting adults with IBS, which compared antidepressants with placebo, or psychological therapies with control therapy or "usual management," were eligible. Dichotomous symptom data were pooled to obtain a relative risk (RR) of remaining symptomatic after therapy, with a 95% confidence interval (CI). The search strategy identified 3,788 citations. Forty-eight RCTs were eligible for inclusion: thirty-one compared psychological therapies with control therapy or "usual management," sixteen compared antidepressants with placebo, and one compared both psychological therapy and antidepressants with placebo. Ten of the trials of psychological therapies, and four of the RCTs of antidepressants, had been published since our previous meta-analysis. The RR of IBS symptom not improving with antidepressants vs. placebo was 0.67 (95% CI=0.58-0.77), with similar treatment effects for both tricyclic antidepressants and selective serotonin reuptake inhibitors. The RR of symptoms not improving with psychological therapies was 0.68 (95% CI=0.61-0.76). Cognitive behavioral therapy, hypnotherapy, multicomponent psychological therapy, and dynamic psychotherapy were all beneficial. Antidepressants and some psychological therapies are effective treatments for IBS. Despite the considerable number of studies published in the intervening 5 years since we last examined this issue, the overall summary estimates of treatment effect have remained remarkably stable.

Original languageEnglish (US)
JournalThe American journal of gastroenterology
Volume109
Issue number9
DOIs
StatePublished - 2014

Fingerprint

Hypnosis
Irritable Bowel Syndrome
Antidepressive Agents
Meta-Analysis
Psychology
Therapeutics
Placebos
Randomized Controlled Trials
Confidence Intervals
Gastrointestinal Diseases
Tricyclic Antidepressive Agents
Serotonin Uptake Inhibitors
Cognitive Therapy
MEDLINE
Psychotherapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome : systematic review and meta-analysis. / Ford, Alexander C.; Quigley, Eamonn M M; Lacy, Brian E.; Lembo, Anthony J.; Saito Loftus, Yuri Ann; Schiller, Lawrence R.; Soffer, Edy E.; Spiegel, Brennan M R; Moayyedi, Paul.

In: The American journal of gastroenterology, Vol. 109, No. 9, 2014.

Research output: Contribution to journalArticle

Ford, Alexander C. ; Quigley, Eamonn M M ; Lacy, Brian E. ; Lembo, Anthony J. ; Saito Loftus, Yuri Ann ; Schiller, Lawrence R. ; Soffer, Edy E. ; Spiegel, Brennan M R ; Moayyedi, Paul. / Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome : systematic review and meta-analysis. In: The American journal of gastroenterology. 2014 ; Vol. 109, No. 9.
@article{43f5fea843a64c53a0daa13ac115445b,
title = "Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.",
abstract = "Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder. Evidence relating to the treatment of this condition with antidepressants and psychological therapies continues to accumulate. We performed an updated systematic review and meta-analysis of randomized controlled trials (RCTs). MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were searched (up to December 2013). Trials recruiting adults with IBS, which compared antidepressants with placebo, or psychological therapies with control therapy or {"}usual management,{"} were eligible. Dichotomous symptom data were pooled to obtain a relative risk (RR) of remaining symptomatic after therapy, with a 95{\%} confidence interval (CI). The search strategy identified 3,788 citations. Forty-eight RCTs were eligible for inclusion: thirty-one compared psychological therapies with control therapy or {"}usual management,{"} sixteen compared antidepressants with placebo, and one compared both psychological therapy and antidepressants with placebo. Ten of the trials of psychological therapies, and four of the RCTs of antidepressants, had been published since our previous meta-analysis. The RR of IBS symptom not improving with antidepressants vs. placebo was 0.67 (95{\%} CI=0.58-0.77), with similar treatment effects for both tricyclic antidepressants and selective serotonin reuptake inhibitors. The RR of symptoms not improving with psychological therapies was 0.68 (95{\%} CI=0.61-0.76). Cognitive behavioral therapy, hypnotherapy, multicomponent psychological therapy, and dynamic psychotherapy were all beneficial. Antidepressants and some psychological therapies are effective treatments for IBS. Despite the considerable number of studies published in the intervening 5 years since we last examined this issue, the overall summary estimates of treatment effect have remained remarkably stable.",
author = "Ford, {Alexander C.} and Quigley, {Eamonn M M} and Lacy, {Brian E.} and Lembo, {Anthony J.} and {Saito Loftus}, {Yuri Ann} and Schiller, {Lawrence R.} and Soffer, {Edy E.} and Spiegel, {Brennan M R} and Paul Moayyedi",
year = "2014",
doi = "10.1038/ajg.2014.148",
language = "English (US)",
volume = "109",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome

T2 - systematic review and meta-analysis.

AU - Ford, Alexander C.

AU - Quigley, Eamonn M M

AU - Lacy, Brian E.

AU - Lembo, Anthony J.

AU - Saito Loftus, Yuri Ann

AU - Schiller, Lawrence R.

AU - Soffer, Edy E.

AU - Spiegel, Brennan M R

AU - Moayyedi, Paul

PY - 2014

Y1 - 2014

N2 - Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder. Evidence relating to the treatment of this condition with antidepressants and psychological therapies continues to accumulate. We performed an updated systematic review and meta-analysis of randomized controlled trials (RCTs). MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were searched (up to December 2013). Trials recruiting adults with IBS, which compared antidepressants with placebo, or psychological therapies with control therapy or "usual management," were eligible. Dichotomous symptom data were pooled to obtain a relative risk (RR) of remaining symptomatic after therapy, with a 95% confidence interval (CI). The search strategy identified 3,788 citations. Forty-eight RCTs were eligible for inclusion: thirty-one compared psychological therapies with control therapy or "usual management," sixteen compared antidepressants with placebo, and one compared both psychological therapy and antidepressants with placebo. Ten of the trials of psychological therapies, and four of the RCTs of antidepressants, had been published since our previous meta-analysis. The RR of IBS symptom not improving with antidepressants vs. placebo was 0.67 (95% CI=0.58-0.77), with similar treatment effects for both tricyclic antidepressants and selective serotonin reuptake inhibitors. The RR of symptoms not improving with psychological therapies was 0.68 (95% CI=0.61-0.76). Cognitive behavioral therapy, hypnotherapy, multicomponent psychological therapy, and dynamic psychotherapy were all beneficial. Antidepressants and some psychological therapies are effective treatments for IBS. Despite the considerable number of studies published in the intervening 5 years since we last examined this issue, the overall summary estimates of treatment effect have remained remarkably stable.

AB - Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder. Evidence relating to the treatment of this condition with antidepressants and psychological therapies continues to accumulate. We performed an updated systematic review and meta-analysis of randomized controlled trials (RCTs). MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were searched (up to December 2013). Trials recruiting adults with IBS, which compared antidepressants with placebo, or psychological therapies with control therapy or "usual management," were eligible. Dichotomous symptom data were pooled to obtain a relative risk (RR) of remaining symptomatic after therapy, with a 95% confidence interval (CI). The search strategy identified 3,788 citations. Forty-eight RCTs were eligible for inclusion: thirty-one compared psychological therapies with control therapy or "usual management," sixteen compared antidepressants with placebo, and one compared both psychological therapy and antidepressants with placebo. Ten of the trials of psychological therapies, and four of the RCTs of antidepressants, had been published since our previous meta-analysis. The RR of IBS symptom not improving with antidepressants vs. placebo was 0.67 (95% CI=0.58-0.77), with similar treatment effects for both tricyclic antidepressants and selective serotonin reuptake inhibitors. The RR of symptoms not improving with psychological therapies was 0.68 (95% CI=0.61-0.76). Cognitive behavioral therapy, hypnotherapy, multicomponent psychological therapy, and dynamic psychotherapy were all beneficial. Antidepressants and some psychological therapies are effective treatments for IBS. Despite the considerable number of studies published in the intervening 5 years since we last examined this issue, the overall summary estimates of treatment effect have remained remarkably stable.

UR - http://www.scopus.com/inward/record.url?scp=84908228349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908228349&partnerID=8YFLogxK

U2 - 10.1038/ajg.2014.148

DO - 10.1038/ajg.2014.148

M3 - Article

C2 - 24935275

AN - SCOPUS:84908228349

VL - 109

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 9

ER -